These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9152482)

  • 1. ESRD modality selection into the 21st century: the importance of non medical factors.
    Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
    ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding criteria for peritoneal dialysis use.
    Palomar R; Arias M
    Panminerva Med; 2009 Sep; 51(3):139-50. PubMed ID: 19859049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the declining use of long-term peritoneal dialysis justified by outcome data?
    Khawar O; Kalantar-Zadeh K; Lo WK; Johnson D; Mehrotra R
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1317-28. PubMed ID: 17942769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries.
    Cantaluppi A; East P
    J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peritoneal dialysis: used too little].
    Fath R
    Dtsch Med Wochenschr; 2004 Mar; 129(11):544. PubMed ID: 15049316
    [No Abstract]   [Full Text] [Related]  

  • 6. HMOs and ESRD: a gloomy scenario.
    Steinman TI
    Nephrol News Issues; 1998 May; 12(5 Suppl):30, 33. PubMed ID: 9652298
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-medical factors that impact on ESRD modality selection.
    Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
    Kidney Int Suppl; 1993 Feb; 40():S120-7. PubMed ID: 8445833
    [No Abstract]   [Full Text] [Related]  

  • 10. Dialysis care in 1999: reality and challenges.
    Bosch JP; Bander S
    J Nephrol; 2000; 13 Suppl 3():S7-9. PubMed ID: 11132036
    [No Abstract]   [Full Text] [Related]  

  • 11. Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist.
    Shahab I; Khanna R; Nolph KD
    Adv Perit Dial; 2006; 22():180-5. PubMed ID: 16983966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining trend of peritoneal dialysis: a single-center experience.
    Agraharkar M; Henry S; Martinez D; Bonds B
    Adv Perit Dial; 2002; 18():100-5. PubMed ID: 12402598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESRD quality assessment, assurance, improvement: a retrospective review and a look ahead.
    Burrows-Hudson S; Vlchek D
    Nephrol News Issues; 1997 Feb; 11(2):13-4, 62. PubMed ID: 9096456
    [No Abstract]   [Full Text] [Related]  

  • 14. Public-private partnership in Hungarian dialysis care.
    Boncz I; Sebestyén A; Pintér I
    Nephrol Dial Transplant; 2006 Jul; 21(7):2024-5; author reply 2025. PubMed ID: 16644780
    [No Abstract]   [Full Text] [Related]  

  • 15. Making peritoneal dialysis and home hemodialysis more economically viable.
    Sullivan JD
    Nephrol News Issues; 2006 Jul; 20(8):54, 56-8. PubMed ID: 16859233
    [No Abstract]   [Full Text] [Related]  

  • 16. End-stage renal diseases in patients 75 and over: a new medical, socio-economical and ethical challenge.
    Mignon F; Michel C; Viron B; Mentre F; Jaar B
    Eur J Med; 1992 Sep; 1(5):302-7. PubMed ID: 1341612
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Dialysis or Hemodialysis: Present and Future Trends in the United States.
    Kaplan AA
    Contrib Nephrol; 2017; 189():61-64. PubMed ID: 27951550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing face of renal care providers: who will dominate the market?
    Neumann ME
    Nephrol News Issues; 1995 Jul; 9(7):14-5, 19. PubMed ID: 7566197
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.